Escibu-LS Tablet
Marketer
Buren Laboratories Ltd
Salt Composition
Clonazepam (0.25mg) + Escitalopram Oxalate (10mg)
Overview Escibu-LS Tablet
TranquilMind-LS tablets are a prescription medication for anxiety. This combination drug reduces excessive nerve cell activity in the brain, promoting calmness. It also elevates levels of key brain chemicals, improving mood. TranquilMind-LS may be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation can trigger withdrawal. Common side effects include decreased libido, delayed ejaculation, nausea, memory problems, depression, and confusion; dizziness and drowsiness may also occur. Avoid driving or tasks requiring concentration until the drug's effects are known. Weight fluctuations (gain or loss) are possible; a balanced diet and exercise can help manage weight gain, while increased food intake might counteract weight loss. Report any unusual mood changes to your doctor immediately, as suicidal thoughts may arise. Caution is advised if you have liver disease. Disclose all other medications you are using, as interactions may reduce efficacy or alter the drug's effects. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Escibu-LS Tablet
No information provided. Therefore, no rephrased text can be given.
Uses of Escibu-LS Tablet
Managing Anxiety: A Therapeutic Approach
Major Benefits of Escibu-LS Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Escibu-LS Tablets. Swallow the tablet whole; do not crush, chew, or break it. Consumption with or without food is acceptable, however, consistent timing is recommended.
Common Side effects of Escibu-LS Tablet:
- Delayed ejaculation
- Confusion
- Vomiting
- Memory impairment
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Nausea
- Diarrhea
- Uncoordinated body movements
How to use Escibu-LS Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Escibu-LS Tablets can be administered with or without food, although consistent timing is recommended.
How Escibu-LS Tablet works:
Escibu-LS Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Escibu-LS Tablets.
PregnancyCONSULT YOUR DOCTOR
Use of Escibu-LS Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Escibu-LS tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Escibu-LS Tablet.
KidneySAFE IF PRESCRIBED
Escibu-LS Tablets appear safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is recommended. Patients with end-stage renal disease may experience pronounced drowsiness when using Escibu-LS Tablets.
LiverCAUTION
Patients with liver impairment should exercise caution when using Escibu-LS tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Escibu-LS Tablet :
Should you forget a dose of Escibu-LS Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Escibu-LS Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience Central Nervous System |



